{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:46:39Z","timestamp":1792597599877,"version":"4.5.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"abstract":"<jats:p>This cohort study examines the steroid-sparing potential and safety profile of interleukin 5 inhibitors for drug reaction with eosinophilia and systemic symptoms.<\/jats:p>","DOI":"10.1001\/jamadermatol.2026.4078","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:32Z","timestamp":1792594832000},"source":"Crossref","is-referenced-by-count":0,"title":["Interleukin 5 Inhibitors and Steroid-Sparing Effects in Drug Reaction With Eosinophilia and Systemic Symptoms"],"prefix":"10.1001","author":[{"given":"Beatrix B.","family":"Thompson","sequence":"first","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Corey","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baraa","family":"Hijaz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Kaundinya","sequence":"additional","affiliation":[{"name":"Harvard Combined Dermatology Residency Program, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod E.","family":"Nambudiri","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotonye","family":"Imadojemu","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline E.","family":"DeWane","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Iriarte","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"5","key":"dld260028r1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jaad.2023.02.072","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.","volume":"90","author":"Wei","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"23","key":"dld260028r2","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1056\/NEJMra2204547","article-title":"Drug reaction with eosinophilia and systemic symptoms.","volume":"391","author":"Kroshinsky","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"dld260028r3","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1111\/all.15283","article-title":"Targeting interleukin-5 with benralizumab: a novel treatment for drug rash with eosinophilia and systemic symptoms.","volume":"77","author":"Maverakis","year":"2022","journal-title":"Allergy"},{"issue":"6","key":"dld260028r4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jamadermatol.2020.0048","article-title":"Evaluation of cyclosporine for the treatment of DRESS syndrome.","volume":"156","author":"Nguyen","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"8","key":"dld260028r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.100935","article-title":"The systemic treatments for drug reaction with eosinophilia and systemic symptoms (DRESS) beyond corticosteroids.","volume":"17","author":"Wang","year":"2024","journal-title":"World Allergy Organ J"},{"key":"dld260028r6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s40629-022-00224-7","article-title":"Treatment with IL5-\/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS).","volume":"32","author":"Gschwend","year":"2022","journal-title":"Allergo J Int"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2855607\/jamadermatology_thompson_2026_ld_260028_1792006446.90884.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:32Z","timestamp":1792594832000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2855607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":6,"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2026.4078","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,21]]}}}